Aisling Capital Iv, Lp - Net Worth and Insider Trading
Aisling Capital Iv, Lp Net Worth
The estimated net worth of Aisling Capital Iv, Lp is at least $2 Million dollars as of 2024-09-20. Aisling Capital Iv, Lp is the 10% Owner of Sunesis Pharmaceuticals Inc and owns about 288,571 shares of Sunesis Pharmaceuticals Inc (SNSS) stock worth over $2 Million. Details can be seen in Aisling Capital Iv, Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Aisling Capital Iv, Lp has not made any transactions after 2019-07-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Aisling Capital Iv, Lp
Aisling Capital Iv, Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Aisling Capital Iv, Lp owns 4 companies in total, including Zosano Pharma Corp (ZSANQ) , Sunesis Pharmaceuticals Inc (SNSS) , and Viracta Therapeutics Inc (VIRX) among others .
Click here to see the complete history of Aisling Capital Iv, Lp’s form 4 insider trades.
Insider Ownership Summary of Aisling Capital Iv, Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ZSANQ | Zosano Pharma Corp | 2019-04-11 | 10 percent owner |
| SNSS | Sunesis Pharmaceuticals Inc | 2019-07-15 | 10 percent owner |
| VIRX | Viracta Therapeutics Inc | 2019-01-23 | 10 percent owner |
 | | 2021-06-24 | 10 percent owner |
Aisling Capital Iv, Lp Latest Holdings Summary
Aisling Capital Iv, Lp currently owns a total of 1 stock. Aisling Capital Iv, Lp owns 288,571 shares of Sunesis Pharmaceuticals Inc (SNSS) as of July 15, 2019, with a value of $2 Million.
Latest Holdings of Aisling Capital Iv, Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SNSS | Sunesis Pharmaceuticals Inc | 2019-07-15 | 288,571 | 5.32 | 1,535,198 |
Holding Weightings of Aisling Capital Iv, Lp
Aisling Capital Iv, Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Aisling Capital Iv, Lp has made a total of 0 transactions in Sunesis Pharmaceuticals Inc (SNSS) over the past 5 years. The most-recent trade in Sunesis Pharmaceuticals Inc is the acquisition of 71,429 shares on July 15, 2019, which cost Aisling Capital Iv, Lp around $2 Million.
Insider Trading History of Aisling Capital Iv, Lp
- 1
Aisling Capital Iv, Lp Trading Performance
GuruFocus tracks the stock performance after each of Aisling Capital Iv, Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Aisling Capital Iv, Lp is -27.9%. GuruFocus also compares Aisling Capital Iv, Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Aisling Capital Iv, Lp within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Aisling Capital Iv, Lp's insider trading performs compared to the benchmark.
Performance of Aisling Capital Iv, Lp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -9.57 | | | | | |
| Relative Return to S&P 500(%) | -4.04 | | | | | |
Aisling Capital Iv, Lp Ownership Network
Aisling Capital Iv, Lp Owned Company Details
What does Zosano Pharma Corp do?
Who are the key executives at Zosano Pharma Corp?
Aisling Capital Iv, Lp is the 10 percent owner of Zosano Pharma Corp. Other key executives at Zosano Pharma Corp include Chief Financial Officer Christine Matthews , director & Chief Executive Officer Steven Lo , and VP & Clinical Dev & Med Affairs Donald J Kellerman .
Zosano Pharma Corp (ZSANQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Zosano Pharma Corp (ZSANQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zosano Pharma Corp (ZSANQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Zosano Pharma Corp (ZSANQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zosano Pharma Corp Insider Transactions
Aisling Capital Iv, Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Aisling Capital Iv, Lp. You might contact Aisling Capital Iv, Lp via mailing address: 888 Seventh Avenue, 12th Floor, New York Ny 10106.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
